Sean Lee
Stock Analyst at HC Wainwright & Co.
(1.59)
# 1480
Out of 5,240 analysts
96
Total ratings
37.29%
Success rate
16.98%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Corvus Pharma | Reiterates: Buy | 11 11 | 5.1 | 115.69% | 2 | Jan 14, 2025 | |
Alphatec Holdings | Reiterates: Buy | 20 20 | 11.08 | 80.51% | 11 | Jan 14, 2025 | |
Verastem | Reiterates: Buy | 7 7 | 5.05 | 38.61% | 12 | Dec 19, 2024 | |
Plus Therapeutics | Reiterates: Buy | 8 | 1.17 | 583.76% | 10 | Nov 26, 2024 | |
Myomo | Reiterates: Buy | 8 8 | 6.08 | 23.36% | 4 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 22 | 24.9 | -11.65% | 8 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1 1 | 1.04 | -3.85% | 11 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 5 | n/a | n/a | 4 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 4 1 | n/a | n/a | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 20 | 1.51 | 1224.5% | 4 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 6 | 2.56 | 134.38% | 7 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | 1.15 | 2508.7% | 1 | Dec 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Mar 19, 2021 |